Practical Application of Setting up an Annual Contamination Control Strategy (CCS) Assessment

References

1. 1.↵
   European Commission, EudraLex—The Rules Governing Medicinal Products in the European Union, Volume 4: Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use, Annex 2, Manufacture of Biological Active Substances and Medicinal Products for Human Use. European Commission: Brussels, 2018. https://ec.europa.eu/health/system/files/2019-02/2018_annex2_en_0.pdf (Accessed July 1, 2024).
2. 2.↵
   International Conference for Harmonisation. Harmonised Tripartate Guideline Q10: Pharmaceutical Quality System. ICH: Geneva, 2008. https://database.ich.org/sites/default/files/Q10%20Guideline.pdf (Accessed July 1, 2024).
3. 3.↵
   European Commission, EudraLex—The Rules Governing Medicinal Products in the European Union, Volume 4: Good Manufacturing Practice for Medicinal Products for Human and Veterinary Use, Annex 1, Manufacture of Sterile Medicinal Products. European Commission: Brussels, 2008. https://ec.europa.eu/health/system/files/2016-11/2008_11_25_gmp-an1_en_0.pdf (Accessed July 1, 2024).
4. 4.↵
   1. van der Galiën R.,
   2. Langen A. L.,
   3. Jacobs L. J. M.,
   4. Hagen B.,
   5. Flahive K.,
   6. Chatterjee S. D.,
   7. van Amsterdam M. C.

   (2023) – Setup of a Contamination Control Strategy Using the Hazard Analysis Critical Control Point (HACCP) Methodology. PDA J. Pharm. Sci. Technol. 2023, 77 (4), 317–328

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. El Azab W.

   Contamination Control Strategy: Implementation Road Map. PDA J. Pharm. Sci. Technol. 2021, 75 (5), 445–453.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   Parenteral Drug Association Inc. Technical Report. No. 90: Contamination Control Strategy Development in Pharmaceutical Manufacturing; Bethesda, MD, 2023. https://kh.aquaenergyexpo.com/wp-content/uploads/2023/06/Best-guide-for-contamination-control-strategy-CCS-.pdf (Accessed November 19, 2024).
7. 7.↵
   ECA Task Force on Contamination Control Strategy. CCS Guideline version 2.0; 2022. https://www.scribd.com/document/628514745/20220119-ECA-Task-Force-CCS-Guideline-Vers2 (Accessed July 5, 2024).
8. 8.↵
   International Conference for Harmonisation. Quality Guideline Q9: Quality Risk Management. ICH: Geneva, 2008. https://www.ema.europa.eu/en/documents/scientific-guideline/international-conference-harmonisation-technical-requirements-registration-pharmaceuticals-human-use-ich-guideline-q9-quality-risk-management-step-5-first-version_en.pdf (Accessed July 5, 2024).
9. 9.↵
   1. Sandle T.,
   2. Leavy C.,
   3. Di Mattia M.

   (2019) - Use of Hazard Analysis Critical Control Point (HACCP) Methodology for Biocontamination Control: Assessing Microbial Risks and to Determining Environmental Monitoring Locations. Eur. J. Parenter. Pharm. Sci. 2019, 243 18–45.

   OpenUrl
10. 10.↵
    1. Gillings N.,
    2. Hjelstuen O.,
    3. Behe M.,
    4. Decristoforo C.,
    5. Elsinga P. H.,
    6. Ferrari V.,
    7. Kiss O. C.,
    8. Kolenc P.,
    9. Koziorowski J.,
    10. Laverman P.,
    11. Mindt T. L.,
    12. Ocak M.,
    13. Patt M.,
    14. Todde S.,
    15. Walte A.

    EANM Guideline on Quality Risk Management for Radiopharmaceuticals. Eur. J. Nucl. Med. Mol. Imaging 2022, 49 (10), 3353–3364.

    OpenUrlPubMed